Chromatin activity of IκBα mediates the exit from naïve pluripotency.
Saved in:
| Title: | Chromatin activity of IκBα mediates the exit from naïve pluripotency. |
|---|---|
| Authors: | Palma LG; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Alvarez-Villanueva D; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain., Maqueda M; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Barrero M; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Iglesias A; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Bertran J; Universitat de Vic - Universitat Central de Catalunya, Vic, Spain., Alvarez D; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Garcia-Prieto CA; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Ballare C; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rodriguez-Cortez V; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Vidal A; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain., Villanueva A; Catalan Institute of Oncology (ICO/IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Menendez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Spanish Network for Advanced Therapies (RICORS-TERAV). Carlos III Health Institute (ISCIII), Madrid, Spain.; Department of Biomedicine. University of Barcelona, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain., Stik G; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Di Croce L; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Payer B; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Esteller M; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Barcelona, Spain., Espinosa L; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Bigas A; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. |
| Source: | ELife [Elife] 2025 Oct 22; Vol. 14. Date of Electronic Publication: 2025 Oct 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41123589 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chromatin activity of IκBα mediates the exit from naïve pluripotency. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Palma+LG%22">Palma LG</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez-Villanueva+D%22">Alvarez-Villanueva D</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Maqueda+M%22">Maqueda M</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Barrero+M%22">Barrero M</searchLink>; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Iglesias+A%22">Iglesias A</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bertran+J%22">Bertran J</searchLink>; Universitat de Vic - Universitat Central de Catalunya, Vic, Spain.<br /><searchLink fieldCode="AU" term="%22Alvarez+D%22">Alvarez D</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Prieto+CA%22">Garcia-Prieto CA</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ballare+C%22">Ballare C</searchLink>; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Cortez+V%22">Rodriguez-Cortez V</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Bueno+C%22">Bueno C</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+A%22">Vidal A</searchLink>; Institut Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobrega, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Villanueva+A%22">Villanueva A</searchLink>; Catalan Institute of Oncology (ICO/IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Menendez+P%22">Menendez P</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Spanish Network for Advanced Therapies (RICORS-TERAV). Carlos III Health Institute (ISCIII), Madrid, Spain.; Department of Biomedicine. University of Barcelona, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Stik+G%22">Stik G</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Di+Croce+L%22">Di Croce L</searchLink>; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Payer+B%22">Payer B</searchLink>; Centre for Genomic Regulationlation(CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Esteller+M%22">Esteller M</searchLink>; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Institucio Catalana de Recerca i Estudis Avançats(ICREA), Barcelona, Spain.; Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Espinosa+L%22">Espinosa L</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Bigas+A%22">Bigas A</searchLink>; Program in Cancer Research. Hospital del Mar Research Institute, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2025 Oct 22; Vol. 14. <i>Date of Electronic Publication: </i>2025 Oct 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41123589 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.102784 Languages: – Code: eng Text: English Titles: – TitleFull: Chromatin activity of IκBα mediates the exit from naïve pluripotency. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Palma LG – PersonEntity: Name: NameFull: Alvarez-Villanueva D – PersonEntity: Name: NameFull: Maqueda M – PersonEntity: Name: NameFull: Barrero M – PersonEntity: Name: NameFull: Iglesias A – PersonEntity: Name: NameFull: Bertran J – PersonEntity: Name: NameFull: Alvarez D – PersonEntity: Name: NameFull: Garcia-Prieto CA – PersonEntity: Name: NameFull: Ballare C – PersonEntity: Name: NameFull: Rodriguez-Cortez V – PersonEntity: Name: NameFull: Bueno C – PersonEntity: Name: NameFull: Vidal A – PersonEntity: Name: NameFull: Villanueva A – PersonEntity: Name: NameFull: Menendez P – PersonEntity: Name: NameFull: Stik G – PersonEntity: Name: NameFull: Di Croce L – PersonEntity: Name: NameFull: Payer B – PersonEntity: Name: NameFull: Esteller M – PersonEntity: Name: NameFull: Espinosa L – PersonEntity: Name: NameFull: Bigas A IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 10 Text: 2025 Oct 22 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 14 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |
